Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anticancer drug discovery

B I Sikic

    Journal of the National Cancer Institute
    |June 5, 1991
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Phase I and pharmacokinetic study of lexatumumab (HGS-ETR2) given every 2 weeks in patients with advanced solid tumors.

    Annals of oncology : official journal of the European Society for Medical Oncology·2009
    Same author

    Low or absent SPARC expression in acute myeloid leukemia with MLL rearrangements is associated with sensitivity to growth inhibition by exogenous SPARC protein.

    Leukemia·2006
    Same author

    A phase I trial of liposomal doxorubicin, paclitaxel and valspodar (PSC-833), an inhibitor of multidrug resistance.

    Annals of oncology : official journal of the European Society for Medical Oncology·2005
    Same author

    Pharmacokinetic interactions of cyclosporine with etoposide and mitoxantrone in children with acute myeloid leukemia.

    Leukemia·2002
    Same author

    A phase I trial of doxorubicin, paclitaxel, and valspodar (PSC 833), a modulator of multidrug resistance.

    Clinical cancer research : an official journal of the American Association for Cancer Research·2001
    Same author

    Effect of high-dose cyclosporine on etoposide pharmacodynamics in a trial to reverse P-glycoprotein (MDR1 gene) mediated drug resistance.

    Cancer chemotherapy and pharmacology·2001
    Same journal

    Stat Bite: Time trends in lung cancer mortality in four European countries by sex, all ages combined, 1951-2022.

    Journal of the National Cancer Institute·2026
    Same journal

    Racial and ethnic disparities in clinical outcomes of HER2-positive metastatic breast cancer treated with antibody-drug conjugates.

    Journal of the National Cancer Institute·2026
    Same journal

    Breast cancer risk prediction with artificial intelligence: promise, calibration, and clinical readiness.

    Journal of the National Cancer Institute·2026
    Same journal

    RE：Electroacupuncture improves cognitive function and neuropsychiatric symptoms in breast cancer survivors: a pilot randomized controlled trial.

    Journal of the National Cancer Institute·2026
    Same journal

    Worsening frailty and declining quality of life in older survivors of non-metastatic breast cancer.

    Journal of the National Cancer Institute·2026
    Same journal

    Longitudinal effects of comorbidities on brain structure and cognition in older breast cancer survivors.

    Journal of the National Cancer Institute·2026
    See all related articles